These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Voltage-gated sodium channels in neurological disorders. Chahine M; Chatelier A; Babich O; Krupp JJ CNS Neurol Disord Drug Targets; 2008 Apr; 7(2):144-58. PubMed ID: 18537643 [TBL] [Abstract][Full Text] [Related]
29. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Wang SY; Wang GK Cell Signal; 2003 Feb; 15(2):151-9. PubMed ID: 12464386 [TBL] [Abstract][Full Text] [Related]
30. muO conotoxins inhibit NaV channels by interfering with their voltage sensors in domain-2. Leipold E; DeBie H; Zorn S; Borges A; Olivera BM; Terlau H; Heinemann SH Channels (Austin); 2007; 1(4):253-62. PubMed ID: 18698149 [TBL] [Abstract][Full Text] [Related]
31. [Cardiac sodium channelopathy from bench to bedside]. Zhang YM; Zhou N Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568 [No Abstract] [Full Text] [Related]
32. Ligand action on sodium, potassium, and calcium channels: role of permeant ions. Zhorov BS; Tikhonov DB Trends Pharmacol Sci; 2013 Mar; 34(3):154-61. PubMed ID: 23375737 [TBL] [Abstract][Full Text] [Related]
33. Irreversible block of cardiac mutant Na+ channels by batrachotoxin. Wang SY; Tikhonov DB; Mitchell J; Zhorov BS; Wang GK Channels (Austin); 2007; 1(3):179-88. PubMed ID: 18690024 [TBL] [Abstract][Full Text] [Related]
34. Neuronal voltage-gated sodium channel subtypes: key roles in inflammatory and neuropathic pain. Ekberg J; Adams DJ Int J Biochem Cell Biol; 2006; 38(12):2005-10. PubMed ID: 16919992 [TBL] [Abstract][Full Text] [Related]
35. Cardiac channelopathies: The role of sodium channel mutations. Fonseca DJ; Vaz da Silva MJ Rev Port Cardiol (Engl Ed); 2018 Feb; 37(2):179-199. PubMed ID: 29525288 [TBL] [Abstract][Full Text] [Related]
36. Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations. Liu H; Tateyama M; Clancy CE; Abriel H; Kass RS J Gen Physiol; 2002 Jul; 120(1):39-51. PubMed ID: 12084774 [TBL] [Abstract][Full Text] [Related]
37. Genetic modulation of impaired cardiac conduction: sodium channel beta4 subunit missing in action. George AL Circ Res; 2009 Jun; 104(11):1238-9. PubMed ID: 19498209 [No Abstract] [Full Text] [Related]
38. Channelopathies: ion channel defects linked to heritable clinical disorders. Felix R J Med Genet; 2000 Oct; 37(10):729-40. PubMed ID: 11015449 [TBL] [Abstract][Full Text] [Related]
39. Sodium channels, cardiac arrhythmia, and therapeutic strategy. Miller D; Wang L; Zhong J Adv Pharmacol; 2014; 70():367-92. PubMed ID: 24931202 [TBL] [Abstract][Full Text] [Related]
40. The study of sodium channels involved in pain responses using specific modulators. Ji YH; Liu T Sheng Li Xue Bao; 2008 Oct; 60(5):628-34. PubMed ID: 18958371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]